38 |
Klinisk Biokemi i Norden · 4 2018
ble deviation limits for accuracy (Figure 2), and when
handled by intended users, 99 % of the results were
within the limits (Figure 3). Glucose measurements on
Accu-Chek Instant were not affected by haematocrit in
the samples, with haematocrit ranging from 29 – 50 %.
The user-friendliness was rated as satisfactory.
Conclusion
The quality goal for repeatability was fulfilled under
optimal conditions by experienced laboratory per-
sonnel, but not fulfilled under real-life conditions by
intended users (people with diabetes), due to higher
imprecision for glucose concentrations <7 mmol/L.
The quality goal for accuracy was fulfilled both under
optimal conditions and by intended users. The quality
goal for user-friendliness was also fulfilled.
The complete evaluation report is available at
.
Roche Diagnostics Scandinavia AB accepted the
report without further comments.
Foto: Anders Hager.
